Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Sep 7;9(9):CD005258.
doi: 10.1002/14651858.CD005258.pub3.

Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism

Affiliations
Review

Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism

Stavros K Kakkos et al. Cochrane Database Syst Rev. .

Update in

Abstract

Background: It is generally assumed by practitioners and guideline authors that combined modalities (methods of treatment) are more effective than single modalities in preventing venous thromboembolism (VTE), defined as deep vein thrombosis (DVT) or pulmonary embolism (PE), or both. This is an update of the review first published in 2008.

Objectives: The aim of this review was to assess the efficacy of combined intermittent pneumatic leg compression (IPC) and pharmacological prophylaxis versus single modalities in preventing venous thromboembolism.

Search methods: For this update the Cochrane Vascular Information Specialist (CIS) searched the Specialised Register (May 2016). In addition the CIS searched the Cochrane Register of Studies (CENTRAL (2016, Issue 4)). Clinical trials databases were searched for details of ongoing or unpublished studies.

Selection criteria: Randomized controlled trials (RCTs) or controlled clinical trials (CCTs) of combined IPC and pharmacological interventions used to prevent VTE.

Data collection and analysis: We independently selected trials and extracted data. Disagreements were resolved by discussion. We performed fixed-effect model meta-analyses with odds ratios (ORs) and 95% confidence intervals (CIs). We used a random-effects model when there was heterogeneity.

Main results: We included a total of 22 trials (9137 participants) of which 15 were randomized trials (7762 participants). The overall risk of bias was mostly unclear or high due to selection and performance bias. We used GRADE to assess the quality of the evidence and this was downgraded from high to moderate or very low due to the risk of bias, imprecision or indirectness.The rate of PE in the studies comparing IPC alone with combined IPC and pharmacological prophylaxis was low, underpowering the analyses. The incidence of symptomatic PE was 0.79% with IPC, but ranged between 0.1 to 1% with combined IPC and pharmacological prophylaxis (OR 0.49, 95% CI 0.18 to 1.34; 12 studies, 3017 participants, moderate quality evidence). The incidence of DVT was 4.10% in the IPC group and 2.19% in the combined group showing a reduced incidence of DVT in favour of the combined group (OR 0.52, 95% CI 0.33 to 0.82; 11 studies, 2934 participants, moderate quality evidence). The addition of an anticoagulant to IPC, however, increased the risk of any bleeding compared to IPC alone; 0.66% (7/1053) in the IPC group and 4.0% (44/1102) in the combined group (OR 5.04, 95% CI 2.36 to 10.77; 7 studies, 2155 participants, moderate quality evidence). Major bleeding followed a similar pattern; 0.1% (1/1053) in the IPC group to 1.5% (17/1102) in the combined group (OR 6.81, 95% CI 1.99 to 23.28; 7 studies, 2155 participants, moderate quality evidence).We detected no difference between the type of surgery subgroups such as orthopedic and non-orthopedic participants for DVT incidence (P = 0.16). Tests for differences between type of surgery subgroups were not possible for PE incidence.Compared with pharmacological prophylaxis alone, the use of combined IPC and pharmacological prophylaxis modalities reduced the incidence of symptomatic PE from 2.92% to 1.20% (OR 0.39, 95% CI 0.23 to 0.64; 10 studies, 3544 participants, moderate quality evidence). The incidence of DVT was 6.2% in the pharmacological prophylaxis group and 2.9% in the combined group showing no difference between the combined and pharmacological prophylaxis groups (OR 0.42, 95% CI 0.18 to 1.03; 11 studies, 2866 participants, moderate quality evidence). Increased bleeding side effects were not observed for IPC when it was added to anticoagulation (bleeding: OR 0.80, 95% CI 0.30 to 2.14, very low quality evidence; major bleeding: OR 1.21, 95% CI 0.35 to 4.18, very low quality evidence, 3 studies, 244 participants).No difference was detected between the type of surgery subgroups for PE incidence (P = 0.68) or for DVT incidence (P = 0.10).

Authors' conclusions: Moderate quality evidence suggests that combining IPC and pharmacological prophylaxis, compared with IPC or pharmacological prophylaxis alone, decreases the incidence of DVT when compared to compression, and incidence of PE when compared to anticoagulation. Moderate quality evidence suggests that there is no difference between combined and single modalities in the incidence of PE when compared with compression alone and DVT when compared with anticoagulation alone. The quality of evidence for PE or DVT was downgraded to moderate due to imprecision or risk of bias in study methodology, highlighting the need for further research. Moderate quality evidence suggests the addition of pharmacological prophylaxis to IPC, increased the risk of bleeding compared to IPC alone, a side effect not observed for IPC when added to pharmacological prophylaxis (very low quality evidence), as expected for a physical method of thromboprophylaxis. The quality of evidence for bleeding was downgraded to moderate due to indirectness or very low due to risk of bias in study methodology, indirectness and imprecision highlighting the need for further research. Nevertheless, the results of the current review agree with current guideline recommendations, which support the use of combined modalities in hospitalised patients (limited to those with trauma or undergoing surgery) at risk of developing VTE. More studies on the role of combined modalities in VTE prevention are needed.

PubMed Disclaimer

Conflict of interest statement

SKK: has declared that he has received consulting fees from Covidien (small lecture fees from companies now taken over and incorporated by Covidien), Sanofi (research funding and travel grants), LEO (research funding), Bayer (research funding and travel grants), all unrelated to the subject of this review JC: has declared that he received consultancy fees from Janssen Research and Development (meeting to discuss protocol), Pfizer (meeting to discuss bleeding issues) and BMS Medtronics (advisory board meeting consultant). He received payment for lectures from Sanofi Poland (lecture to Vascular surgical society) and CHEST enterprises (lectures to Pharma group concerning guidelines). These were unrelated to the subject of this review GG: none known AN: none known GS: none known DR: none known IN: none known

Figures

1
1
Study flow diagram.
2
2
Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
3
3
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.

References

References to studies included in this review

Bigg 1992 {published data only}
    1. Bigg SW, Catalona WJ. Prophylactic mini‐dose heparin in patients undergoing radical retropubic prostatectomy. A prospective trial. Urology 1992;39(4):309‐13. - PubMed
Borow 1983 {published data only}
    1. Borow M, Goldson HJ. Prevention of postoperative deep venous thrombosis and pulmonary emboli with combined modalities. American Surgeon 1983;49(11):599‐605. - PubMed
Bradley 1993 {published data only}
    1. Bradley JG, Krugener GH, Jager HJ. The effectiveness of intermittent plantar venous compression in prevention of deep venous thrombosis after total hip arthroplasty. Journal of Arthroplasty 1993;8(1):57‐61. - PubMed
Cahan 2000 {published data only}
    1. Cahan MA, Hanna DJ, Wiley LA, Cox DK, Killewich LA. External pneumatic compression and fibrinolysis in abdominal surgery. Journal of Vascular Surgery 2000;32(3):537‐43. - PubMed
Dickinson 1998 {published data only}
    1. Dickinson LD, Miller LD, Patel CP, Gupta SK. Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery 1998;43(5):1074–81. - PubMed
Edwards 2008 {published data only}
    1. Edwards JZ, Pulido PA, Ezzet KA, Copp SN, Walker RH, Colwell CW Jr. Portable compression device and low‐molecular‐weight heparin compared with low‐molecular‐weight heparin for thromboprophylaxis after total joint arthroplasty. Journal of Arthroplasty 2008;23(8):1122‐7. - PubMed
Eisele 2007 {published data only}
    1. Eisele R, Kinzl L, Koelsch T. Rapid‐inflation intermittent pneumatic compression for prevention of deep venous thrombosis. Journal of Bone and Joint Surgery ‐ American Volume 2007;89(5):1050‐6. - PubMed
Kurtoglu 2003 {published data only}
    1. Kurtoglu M, Aksoy M, Genc FA, Baktiroglu S. The efficacy of intermittent pneumatic compression devices in combination with or without low molecular weight heparin in the prophylaxis of venous thromboembolism in patients with trauma. Phlebology 2003;18(3):148.
    1. Yanar H, Kurtoglu M, Taviloglu K, Guloglu R, Ertekin C. Does intermittent pneumatic compression make low molecular weight heparin more efficient in the prophylaxis of venous thromboembolism in trauma patients. European Journal of Trauma and Emergency Surgery 2007;33(Suppl II):79‐80.
Ramos 1996 {published data only}
    1. Ramos R, Salem BI, Pawlikowski MP, Coordes C, Eisenberg S, Leidenfrost R. The efficacy of pneumatic compression stockings in the prevention of pulmonary embolism after cardiac surgery. Chest 1996;109(1):82‐5. - PubMed
Sakai 2016 {published data only}
    1. Sakai T, Izumi M, Kumagai K, Kidera K, Yamaguchi T, Asahara T, et al. Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban: a randomized controlled study. Medicine (Baltimore) 2016;95(1):e2247. - PMC - PubMed
Sieber 1997 {published data only}
    1. Sieber PR, Rommel FM, Agusta VE, Breslin JA, Harpster LE, Huffnagle HW, Stahl C. Is heparin contraindicated in pelvic lymphadenectomy and radical prostatectomy?. Journal of Urology 1997;158(3 pt1):869‐71. - PubMed
Silbersack 2004 {published data only}
    1. Silbersack Y, Taute BM, Hein W, Podhaisky H. Prevention of deep‐vein thrombosis after total hip and knee replacement. Low‐molecular‐weight heparin in combination with intermittent pneumatic compression. Journal of Bone and Joint Surgery ‐ British Volume 2004;86(6):809‐12. - PubMed
Siragusa 1994 {published data only}
    1. Siragusa S, Vicentini L, Carbone S, Barone M, Beltrametti C, Piovella F. Intermittent pneumatic leg compression (IPLC) and unfractionated heparin (UFH) in the prevention of post‐operative deep vein thrombosis in hip surgery: a randomized clinical trial. British Journal of Haematology 1994;87(Suppl 1):186.
Song 2014 {published data only}
    1. Song KY, Yoo HM, Kim EY, Kim JI, Yim HW, Jeon HM, et al. Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: an interim analysis of prospective randomized trial. Annals of Surgical Oncology 2014;21(13):4232‐8. - PubMed
Stannard 1996 {published data only}
    1. Stannard JP, Harris RM, Bucknell AL, Cossi A, Ward J, Arrington ED. Prophylaxis of deep venous thrombosis after total hip arthroplasty by using intermittent compression of the plantar venous plexus. American Journal of Orthopedics 1996;25:127–34. - PubMed
Tsutsumi 2012 {published data only}
    1. Tsutsumi S, Yajima R, Tabe Y, Takaaki T, Fujii F, Morita H, et al. The efficacy of fondaparinux for the prophylaxis of venous thromboembolism after resection for colorectal cancer. Hepatogastroenterology 2012;59:2477‐9. - PubMed
Turpie 2007 {published data only}
    1. Priore G, Herzog TJ, Bauer KA, Caprini JA, Comp P, Gent M, et al. Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: results of the APOLLO study. Gynecologic Oncology 2006;101:S21.
    1. Turpie AGG, Bauer KA, Caprini JA, Comp PC, Gent M, Muntz JE, on behalf of the APOLLO Investigators. Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double‐blind comparison. Journal of Thrombosis and Haemostasis 2007;5(9):1854‐61. - PubMed
    1. Turpie AGG, Bauer KA, Caprini JA, Comp PP, Gent M, Muntz JE. Fondaparinux combined with intermittent pneumatic compression (IPC) versus IPC alone in the prevention of venous thromboembolism after major abdominal surgery: the randomized APOLLO study. Blood 2005;106(11):Abstract 279.
Westrich 2005 {published data only}
    1. Westrich GH, Rana AJ, Terry MA, Taveras NA, Kapoor K, Helfet DL. Thromboembolic disease prophylaxis in patients with hip fracture: a multimodal approach. Journal of Orthopaedic Trauma 2005;19(4):234‐40. - PubMed
Westrich 2006 {published data only}
    1. Westrich GH, Bottner F, Windsor RE, Laskin RS, Haas SB, Sculco TP. VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty. Journal of Arthroplasty 2006;21(6 Suppl 2):139‐43. - PubMed
Windisch 2011 {published data only}
    1. Windisch C, Kolb W, Kolb K, Grützner P, Venbrocks R, Anders J. Pneumatic compression with foot pumps facilitates early postoperative mobilisation in total knee arthroplasty. International Orthopaedics 2011;35(7):995‐1000. - PMC - PubMed
Woolson 1991 {published data only}
    1. Woolson ST, Watt JM. Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective, randomized study of compression alone, compression and aspirin, and compression and low‐dose warfarin. Journal of Bone and Joint Surgery ‐ American Volume 1991;73(4):507‐12. - PubMed
Yokote 2011 {published data only}
    1. Yokote R, Matsubara M, Hirasawa N, Hagio S, Ishii K, Takata C. Is routine chemical thromboprophylaxis after total hip replacement really necessary in a Japanese population?. Journal of Bone and Joint Surgery. British Volume 2011;93(2):251‐6. - PubMed

References to studies excluded from this review

Ailawadi 2001 {published data only}
    1. Ailawadi M, Priore G. A comparison of thromboembolic prophylaxis in gynecologic oncology patients. International Journal of Gynecological Cancer 2001;11(5):354‐8. - PubMed
Eskander 1997 {published data only}
    1. Eskander MB, Limb D, Stone MH, Furlong AJ, Shardlow D, Stead D, et al. Sequential mechanical and pharmacological thromboprophylaxis in the surgery of hip fractures: A pilot study. International Orthopaedics 1997;21(4):259‐61. - PMC - PubMed
Frim 1992 {published data only}
    1. Frim DM, Barker FG 2nd, Poletti CE, Hamilton AJ. Postoperative low‐dose heparin decreases thromboembolic complications in neurosurgical patients. Neurosurgery 1992;30(6):830‐2. - PubMed
Gagner 2012 {published data only}
    1. Gagner M, Selzer F, Belle SH, Bessler M, Courcoulas AP, Dakin GF, et al. Adding chemoprophylaxis to sequential compression might not reduce risk of venous thromboembolism in bariatric surgery patients. Surgery for Obesity and Related Diseases 2012;8(6):663‐70. - PMC - PubMed
Gelfer 2006 {published data only}
    1. Gelfer Y, Tavor H, Oron A, Peer A, Halperin N, Robinson D. Deep vein thrombosis prevention in joint arthroplasties: continuous enhanced circulation therapy vs low molecular weight heparin. Journal of Arthroplasty 2006;21(2):206‐14. - PubMed
Kamran 1998 {published data only}
    1. Kamran SI, Downey D, Ruff RL. Pneumatic sequential compression reduces the risk of deep vein thrombosis in stroke patients. Neurology 1998;50(6):1683‐8. - PubMed
Kiudelis 2010 {published data only}
    1. Kiudelis M, Gerbutavicius R, Gerbutaviciene R, Griniūte R, Mickevicius A, Endzinas Z, et al. A combinative effect of low‐molecular‐weight heparin and intermittent pneumatic compression device for thrombosis prevention during laparoscopic fundoplication. Medicina 2010;46:18‐23. - PubMed
Kumaran 2008 {published data only}
    1. Kumaran R, Sokolovic M, Ashame E, George EM, Bernstein L, George L. Prevention of venous thromboembolism in critically ill medical patients. Chest 2008; Vol. 134, issue 4:36003s.
Lieberman 1994 {published data only}
    1. Lieberman JR, Huo MM, Hanway J, Salvati EA, Sculco TP, Sharrock NE. The prevalence of deep venous thrombosis after total hip arthroplasty with hypotensive epidural anesthesia. Journal of Bone and Joint Surgery 1994;76‐A(3):341–8. - PubMed
Macdonald 2003 {published data only}
    1. Macdonald RL, Amidei C, Baron J, Weir B, Brown F, Erickson RK, et al. Randomized, pilot study of intermittent pneumatic compression devices plus dalteparin versus intermittent pneumatic compression devices plus heparin for prevention of venous thromboembolism in patients undergoing craniotomy. Surgical Neurology 2003;59(5):363‐72; discussion 372‐4. - PubMed
Mehta 2010 {published data only}
    1. Mehta KV, Lee HC, Loh JSY. Mechanical thromboprophylaxis for patients undergoing hip fracture surgery. Journal of Orthopaedic Surgery (Hong Kong) 2010;18(3):287‐9. - PubMed
    1. Mehta KV, Lee HC, Loh JSY. Reply to a letter to the Editor re: Mechanical thromboprophylaxis for patients undergoing hip fracture surgery. Journal of Orthopaedic Surgery (Hong Kong) 2011;19(2):260‐2. - PubMed
Nathan 2006 {published data only}
    1. Nathan SS, Simmons KA, Lin PP, Hann LE, Morris CD, Athanasian EA, et al. Proximal deep vein thrombosis after hip replacement for oncologic indications. Journal of Bone and Joint Surgery ‐ American Volume 2006;88(5):1066‐70. - PubMed
Patel 2010 {published data only}
    1. Patel AR, Crist MK, Nemitz J, Mayerson JL. Aspirin and compression devices versus low‐molecular‐weight heparin and PCD for VTE prophylaxis in orthopedic oncology patients. Journal of Surgical Oncology 2010;102:276–81. - PubMed
Roberts 1975 {published data only}
    1. Roberts VC, Cotton LT. Failure of low‐dose heparin to improve efficacy of perioperative intermittent calf compression in preventing postoperative deep vein thrombosis. British Medical Journal 1975;3(5981):458‐60. - PMC - PubMed
Spinal cord injury investigators {published data only}
    1. Spinal Cord Injury Thromboprophylaxis Investigators. Prevention of venous thromboembolism in the acute treatment phase after spinal cord injury: a randomized, multicenter trial comparing low‐dose heparin plus intermittent pneumatic compression with enoxaparin. Journal of Trauma ‐ Injury Infection and Critical Care 2003;54(6):1116‐24; discussion 1125‐6. - PubMed
Stannard 2006 {published data only}
    1. Stannard JP, Lopez‐Ben RR, Volgas DA, Anderson ER, Busbee M, Karr DK, et al. Prophylaxis against deep‐vein thrombosis following trauma: a prospective, randomized comparison of mechanical and pharmacologic prophylaxis. Journal of Bone and Joint Surgery ‐ American Volume 2006;88(2):261‐6. - PubMed
Tsutsumi 2000 {published data only}
    1. Tsutsumi K, Udagawa H, Kajiyama Y, Kinoshita Y, Ueno M, Nakamura T, et al. Pulmonary thromboembolism after surgery for esophageal cancer: its features and prophylaxis. Surgery Today 2000;30(5):416‐20. - PubMed
Wan 2015 {published data only}
    1. Wan B, Fu H‐Y, Yin J‐T, Ren G‐Q. Low‑molecular‑weight heparin and intermittent pneumatic compression for thromboprophylaxis in critical patients. Experimental and Therapeutic Medicine 2015;10(6):2331‐36. - PMC - PubMed
Westrich 1996 {published data only}
    1. Westrich GH, Sculco TP. Prophylaxis against deep venous thrombosis after total knee arthroplasty. Pneumatic plantar compression and aspirin compared with aspirin alone. Journal of Bone and Joint Surgery 1996;78‐A(6):826‐34. - PubMed
Whitworth 2011 {published data only}
    1. Whitworth JM, Schneider KE, Frederick PJ, Finan MA, Reed E, Fauci JM, et al. Double prophylaxis for deep venous thrombosis in patients with gynecologic oncology who are undergoing laparotomy: does preoperative anticoagulation matter?. International Journal of Gynecological Cancer 2011;21(6):1131‐4. - PubMed
Winemiller 1999 {published data only}
    1. Winemiller MH, Stolp‐Smith KA, Silverstein MD, Therneau TM. Prevention of venous thromboembolism in patients with spinal cord injury: effects of sequential pneumatic compression and heparin. Journal of Spinal Cord Medicine 1999;22(3):182‐91. - PubMed

References to ongoing studies

CHICTR‐IPR‐15007324 {published data only}
    1. CHICTR‐IPR‐15007324. The mechanical and medical prevention of lower extremity deep venous thrombosis formation post gynecologic pelvic surgery, a multiple center randomized case control study. http://apps.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR‐IPR‐15007324 (accessed April 2016).
ISRCTN44653506 and NCT02040103 {published data only}
    1. Arabi YM, Alsolamy S, Al‐Dawood A, Al‐Omari A, Al‐Hameed F, Burns KE, et al. Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial. Trials 2016;17:390. [DOI: 10.1186/s13063-016-1520-0] - DOI - PMC - PubMed
    1. ISRCTN44653506. The PREVENT trial: pneumatic compression for preventing venous thromboembolism. http://www.isrctn.com/ISRCTN44653506 Accessed May 2016.
NCT00740987 {published data only}
    1. NCT00740987. Efficacy of the association mechanical prophylaxis + anticoagulant prophylaxis on venous thromboembolism incidence in intensive care unit (ICU) (CIREA2). https://clinicaltrials.gov/ct2/show/NCT00740987 (accessed April 2016).

Additional references

Atkins 2004
    1. Atkins D, Best D, Briss PA, Eccles M, Falck‐Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendations. British Medical Journal 2004;328(7454):1490‐4. - PMC - PubMed
Chouhan 1999
    1. Chouhan VD, Comerota AJ, Sun L, Harada R, Gaughan JP, Rao AK. Inhibition of tissue factor pathway during intermittent pneumatic compression: a possible mechanism for antithrombotic effect. Arteriosclerosis, Thrombosis and Vascular Biology 1999;19(11):2812‐7. - PubMed
Egger 1997
    1. Egger M, Davey SG, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. British Medical Journal (Clinical Research Ed.) 1997;315(7109):629‐34. - PMC - PubMed
Eriksson 2001
    1. Eriksson BI, Bauer KA, Lassen MR, Turpie AG, for the Steering Committee of the Pentasaccharide in Hip‐Fracture Surgery Study. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip‐fracture surgery. New England Journal of Medicine 2001;345(18):1298‐304. - PubMed
Eriksson 2008
    1. Eriksson BI, Borris LC, Friedman RJ, Haas S, Huisman MV, Kakkar AK, et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. New England Journal of Medicine 2008;358(26):2765‐75. - PubMed
Goldhaber 2001
    1. Goldhaber SZ. Prophylaxis of venous thrombosis. Current Treatment Options in Cardiovascular Medicine 2001;3(3):225‐35. - PubMed
Gould 2012
    1. Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA, et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence‐Based Clinical Practice Guidelines. Chest 2012;141:e227S‐e277S. - PMC - PubMed
Higgins 2011
    1. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane‐handbook.org. 2011.
Ho 2013
    1. Ho KM, Tan JA. Stratified meta‐analysis of intermittent pneumatic compression of the lower limbs to prevent venous thromboembolism in hospitalized patients. Circulation 2013;128:1003‐20. - PubMed
Kakkos 2005
    1. Kakkos SK, Griffin M, Geroulakos G, Nicolaides AN. The efficacy of a new portable sequential compression device (SCD Express) in preventing venous stasis. Journal of Vascular Surgery 2005;42(2):296‐303. - PubMed
Kakkos 2012
    1. Kakkos SK, Warwick D, Nicolaides AN, Stansby GP, Tsolakis IA. Combined (mechanical and pharmacological) modalities for VTE prevention in joint arthroplasty. Journal of Bone and Joint Surgery. British Volume 2012;94‐B:729‐34. - PubMed
King 2007
    1. King CS. Twice vs three times daily heparin dosing for thromboembolism prophylaxis in the general medical population: a meta‐analysis. Chest 2007;131(2):507‐16. - PubMed
McLeod 2001
    1. McLeod RS, Geerts WH, Sniderman KW, Greenwood C, Gregoire RC, Taylor BM, et al. Canadian Colorectal Surgery DVT Prophylaxis Trial investigators. Subcutaneous heparin versus low‐molecular‐weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the Canadian colorectal DVT prophylaxis trial: a randomized, double‐blind trial. Annals of Surgery 2001;233(3):438‐44. - PMC - PubMed
NICE 2009
    1. National Clinical Guideline Centre ‐ Acute and chronic conditions. Venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. https://www.nice.org.uk/guidance/cg92/ (accessed April 2016).
Nicolaides 2013
    1. Nicolaides AN, Fareed J, Kakkar AK, Comerota AJ, Goldhaber SZ, Hull R, et al. Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence). International Angiology 2013;32:111‐260. - PubMed
NRSMG
    1. Cochrane Non‐Randomised Studies Methods Group. Draft chapters for the Guidelines on Non‐randomised studies in Cochrane reviews. http://www.cochrane.dk/nrsmg/guidelines.htm 2001 (accessed August 2007).
Piazza 2007
    1. Piazza G, Seddighzadeh A, Goldhaber SZ. Double trouble for 2,609 hospitalized medical patients who developed deep vein thrombosis: prophylaxis omitted more often and pulmonary embolism more frequent. Chest 2007;132(2):554‐61. - PubMed
Rosendaal 1999
    1. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999;353(9159):1167‐73. - PubMed
Schulman 2010
    1. Schulman S, Angerås U, Bergqvist D, Eriksson B, Lassen MR, Fisher W, on behalf of the Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. Journal of Thrombosis and Haemostasis 2010;8(1):202‐4. - PubMed
Sobieraj 2013
    1. Sobieraj DM, Coleman CI, Tongbram V, Chen W, Colby J, Lee S, et al. Comparative effectiveness of combined pharmacologic and mechanical thromboprophylaxis versus either method alone in major orthopedic surgery: a systematic review and meta‐analysis. Pharmacotherapy 2013;33(3):275–83. - PubMed
Virchow 1856
    1. Virchow RLK. Thrombosis and emboli [Phlogose und thrombose im gefässsystem]. Gesammelte Adhandlungen zur Wissenschaftlichen Medicine. Frankfurt am Main: von Meidinger & Sohn, 1856:458‐636.
Zareba 2014
    1. Zareba P, Wu C, Agzarian J, Rodriguez D, Kearon C. Meta‐analysis of randomized trials comparing combined compression and anticoagulation with either modality alone for prevention of venous thromboembolism after surgery. British Journal of Surgery 2014;101:1053–62. - PubMed

References to other published versions of this review

Kakkos 2005a
    1. Kakkos SK, Geroulakos G, Caprini J, Nicolaides AN, Stansby G. Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high risk patients. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD005258] - DOI - PubMed
Kakkos 2008
    1. Kakkos SK, Caprini JA, Geroulakos G, Nicolaides AN, Stansby G, Reddy DJ. Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high‐risk patients. Cochrane Database of Systematic Reviews 2008, Issue 4. [DOI: 10.1002/14651858.CD005258.pub2] - DOI - PubMed